Anti-HYDIN monoclonal antibody

Pre-made anti-HYDIN monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to HYDIN/HYDIN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2544-Ab-1/ GM-Tg-hg-IP2544-Ab-2Anti-Human HYDIN monoclonal antibodyHuman
GM-Tg-rg-IP2544-Ab-1/ GM-Tg-rg-IP2544-Ab-2Anti-Rat HYDIN monoclonal antibodyRat
GM-Tg-mg-IP2544-Ab-1/ GM-Tg-mg-IP2544-Ab-2Anti-Mouse HYDIN monoclonal antibodyMouse
GM-Tg-cynog-IP2544-Ab-1/ GM-Tg-cynog-IP2544-Ab-2Anti-Cynomolgus/ Rhesus macaque HYDIN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2544-Ab-1/ GM-Tg-felg-IP2544-Ab-2Anti-Feline HYDIN monoclonal antibodyFeline
GM-Tg-cang-IP2544-Ab-1/ GM-Tg-cang-IP2544-Ab-2Anti-Canine HYDIN monoclonal antibodyCanine
GM-Tg-bovg-IP2544-Ab-1/ GM-Tg-bovg-IP2544-Ab-2Anti-Bovine HYDIN monoclonal antibodyBovine
GM-Tg-equg-IP2544-Ab-1/ GM-Tg-equg-IP2544-Ab-2Anti-Equine HYDIN monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2544-Ab-1/ GM-Tg-hg-IP2544-Ab-2; GM-Tg-rg-IP2544-Ab-1/ GM-Tg-rg-IP2544-Ab-2;
GM-Tg-mg-IP2544-Ab-1/ GM-Tg-mg-IP2544-Ab-2; GM-Tg-cynog-IP2544-Ab-1/ GM-Tg-cynog-IP2544-Ab-2;
GM-Tg-felg-IP2544-Ab-1/ GM-Tg-felg-IP2544-Ab-2; GM-Tg-cang-IP2544-Ab-1/ GM-Tg-cang-IP2544-Ab-2;
GM-Tg-bovg-IP2544-Ab-1/ GM-Tg-bovg-IP2544-Ab-2; GM-Tg-equg-IP2544-Ab-1/ GM-Tg-equg-IP2544-Ab-2
Products NameAnti-HYDIN monoclonal antibody
Formatmab
Target NameHYDIN
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-HYDIN monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2544-Ag-1Recombinant multi-species HYDIN/ CILD51/ HYDIN2 protein


    Target information

    Target IDGM-IP2544
    Target NameHYDIN
    Gene ID54768,244653,292017,708629,100683062,101093658,102150351
    Gene Symbol and Synonyms1700034M11Rik,4930545D19Rik,4932703P14,672398,A830061H17,AC069308.21gm4,CILD5,Gm9558,hy-3,hy3,HYDIN,HYDIN1,HYDIN2,hyrh,PPP1R31
    Uniprot AccessionQ4G0P3
    Uniprot Entry NameHYDIN_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000157423
    Target ClassificationN/A

    The target: HYDIN, gene name: HYDIN, also named as CILD51, HYDIN2, PPP1R31, HYDIN. This gene encodes a protein that may be involved in cilia motility. Mutations in this gene cause of autosomal recessive primary ciliary dyskinesia-5, a disorder characterized by the accumulation of cerebrospinal fluid within the ventricles of the brain. A duplicate copy of this gene has been found in humans on chromosome 1. [provided by RefSeq, Jan 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.